z-logo
Premium
Management of recurrent alveolar soft‐part sarcoma of the tongue after external beam radiotherapy with iodine‐125 seed brachytherapy
Author(s) -
Meng Na,
Zhang Xiaomeng,
Liao Anyan,
Tian Suqing,
Ran Weiqiang,
Gao Yang,
Wang Jun Jie
Publication year - 2014
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.23648
Subject(s) - alveolar soft part sarcoma , brachytherapy , medicine , radiation therapy , soft tissue , sarcoma , tongue , external beam radiotherapy , head and neck , radiology , chemotherapy , surgery , pathology
Background Alveolar soft part sarcoma (ASPS) is a rare type of soft tissue sarcoma. The infrequency of ASPS is such that it accounts for <1% of all soft tissue sarcomas and <0.1% of sarcomas concerning the head and neck, primarily those involving the orbit (48%) and tongue (25%). Traditional chemotherapy or radiotherapy of ASPS is often associated with poor outcome, even after comprehensive interventions. Methods and Results We performed iodine‐125 ( 125 I) seed brachytherapy under ultrasound guidance through a submandibular puncture in a 4‐year‐old boy with recurrent ASPS of the tongue. The prescription dose was 120 Gy; therefore, 35 125 I seeds were implanted with 0.77 mCi per seed, the total amount of activity being 26.95 mCi. CT scans confirmed a complete response after the treatment. Conclusion Our patient now has a recurrent‐free survival of >30 months, an amount of time longer than the median rate described in the literature. © 2014 Wiley Periodicals, Inc. Head Neck 36: E125–E128, 2014

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom